Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth Quadruple Therapy vs Bismuth Add-on to Clarithromycin Triple Therapy for H. pylori Eradication
NCT07810985Phase 3Completed
- Start
- Sep 2023
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
A Phase 3 trial of bismuth subcitrate in Helicobacter pylori infection. Started Sep 2023; status: completed.
02
Drugs
bismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07810985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07810985.